Pharmaceutical Technology

APRIL 27, 2023

GlobalData pharmaceutical analysts project that RNA-based gene therapies for oncology will grow from zero in 2022 to $4.6 There are currently 885 clinical trials ongoing or completed for prophylactic mRNA vaccines for infectious diseases and double the number of Phase I trials in 2022 compared to 2021.

Manufacturing 130

Manufacturing RNA Contamination Vaccination 130

Advarra

MARCH 31, 2023

The use of engineered genetic materials in clinical trials is rapidly expanding, with potential applications for genetic vaccines, gene-modified cellular therapies, and gene therapies.

Engineer 52

Engineer Genetics Clinical Research Research 52

Roots Analysis

SEPTEMBER 18, 2023

Biologics: Gene therapy and cell therapy-based futuristic treatments fall under the category of advanced therapy medicinal products ( ATMPs ) and offer opportunities to individuals suffering from a variety of illnesses, including various types of cancers.

Engineer 52

Engineer Containment In-Vivo Production 52

Drug Discovery World

AUGUST 10, 2022

For instance, some therapies in development target combinations of antigens to improve the effectiveness and specificity of the therapy 9. Other developers are installing kill switches that allow clinicians to deactivate a therapy that has begun to produce adverse reactions. The next 25 years of CAR T cell therapy development.

Manufacturing 98

Manufacturing Gene Genome Genomics 98